Wellcome Trust and India team up for affordable drugs

The Wellcome Trust has extended its alliance with the Government of India’s Department of Biotechnology, this time setting up a £45 million partnership to develop “innovative healthcare products at affordable costs”

Solid results for Amgen but all eyes on denosumab

Amgen’s adjusted net income for the second quarter has edged up 1% to $1.33 billion, while turnover was up 2% to $3.80 billion